Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

154 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Deep brain stimulation improves survival in severe Parkinson's disease.
Ngoga D, Mitchell R, Kausar J, Hodson J, Harries A, Pall H. Ngoga D, et al. Among authors: pall h. J Neurol Neurosurg Psychiatry. 2014 Jan;85(1):17-22. doi: 10.1136/jnnp-2012-304715. Epub 2013 Jul 10. J Neurol Neurosurg Psychiatry. 2014. PMID: 23843542
Cost-utility analysis of deep brain stimulation surgery plus best medical therapy versus best medical therapy in patients with Parkinson's: Economic evaluation alongside the PD SURG trial.
McIntosh E, Gray A, Daniels J, Gill S, Ives N, Jenkinson C, Mitchell R, Pall H, Patel S, Quinn N, Rick C, Wheatley K, Williams A; PD SURG Collaborators Group. McIntosh E, et al. Among authors: pall h. Mov Disord. 2016 Aug;31(8):1173-82. doi: 10.1002/mds.26423. Epub 2016 Feb 5. Mov Disord. 2016. PMID: 26846185 Clinical Trial.
Deep brain stimulation plus best medical therapy versus best medical therapy alone for advanced Parkinson's disease (PD SURG trial): a randomised, open-label trial.
Williams A, Gill S, Varma T, Jenkinson C, Quinn N, Mitchell R, Scott R, Ives N, Rick C, Daniels J, Patel S, Wheatley K; PD SURG Collaborative Group. Williams A, et al. Lancet Neurol. 2010 Jun;9(6):581-91. doi: 10.1016/S1474-4422(10)70093-4. Epub 2010 Apr 29. Lancet Neurol. 2010. PMID: 20434403 Free PMC article. Clinical Trial.
Long-term Effectiveness of Adjuvant Treatment With Catechol-O-Methyltransferase or Monoamine Oxidase B Inhibitors Compared With Dopamine Agonists Among Patients With Parkinson Disease Uncontrolled by Levodopa Therapy: The PD MED Randomized Clinical Trial.
Gray R, Patel S, Ives N, Rick C, Woolley R, Muzerengi S, Gray A, Jenkinson C, McIntosh E, Wheatley K, Williams A, Clarke CE; PD MED Collaborative Group. Gray R, et al. JAMA Neurol. 2022 Feb 1;79(2):131-140. doi: 10.1001/jamaneurol.2021.4736. JAMA Neurol. 2022. PMID: 34962574 Free PMC article. Clinical Trial.
154 results